Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Share-based Compensation (2019 - 2025)

Historic Share-based Compensation for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $4.1 million.

  • Outset Medical's Share-based Compensation fell 1783.62% to $4.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $15.6 million, marking a year-over-year decrease of 4680.47%. This contributed to the annual value of $15.6 million for FY2025, which is 4680.47% down from last year.
  • Latest data reveals that Outset Medical reported Share-based Compensation of $4.1 million as of Q4 2025, which was down 1783.62% from $5.1 million recorded in Q3 2025.
  • In the past 5 years, Outset Medical's Share-based Compensation ranged from a high of $10.9 million in Q3 2023 and a low of $2.9 million during Q3 2021
  • For the 5-year period, Outset Medical's Share-based Compensation averaged around $6.4 million, with its median value being $6.1 million (2021).
  • The largest annual percentage gain for Outset Medical's Share-based Compensation in the last 5 years was 90896.55% (2021), contrasted with its biggest fall of 7940.75% (2021).
  • Over the past 5 years, Outset Medical's Share-based Compensation (Quarter) stood at $4.8 million in 2021, then surged by 53.44% to $7.4 million in 2022, then increased by 23.73% to $9.1 million in 2023, then plummeted by 45.65% to $4.9 million in 2024, then fell by 17.84% to $4.1 million in 2025.
  • Its Share-based Compensation was $4.1 million in Q4 2025, compared to $5.1 million in Q3 2025 and $3.5 million in Q2 2025.